Home LiteratureArticle Details
PMID: 6319291 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2.

Infection and immunity ·Vol. 43 ·No. 2 ·1984-02-00 ·Pages 761-4

Long D, Madara TJ, Ponce de Leon M, Cohen GH, Montgomery PC, Eisenberg RJ

Abstract

Glycoprotein D is a virion envelope component of herpes simplex virus types 1 and 2. Sets of mice were immunized with purified gD-1 or gD-2 and were challenged with a lethal dose of herpes simple virus, either type 1 or type 2. All or virtually all of the immunized mice survived challenge with either agent, whereas challenge of sham-immunized mice was almost always fatal. Serum samples taken before challenge contained gD-specific antibodies which had 50% neutralization titers ranging from 1:16 to 1:512 against homologous and heterologous virus types. We conclude that either gD-1 or gD-2 is a potential candidate for a subunit vaccine against herpetic infections.

MeSH Terms
Animals Electrophoresis, Polyacrylamide Gel Glycoproteins/immunology Immunization, Passive Mice Mice, Inbred BALB C Simplexvirus/immunology Viral Envelope Proteins/immunology
Chemicals
Glycoproteins Viral Envelope Proteins
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Long D
Madara T J
Ponce de Leon M
Cohen G H
Montgomery P C
Eisenberg R J
References (26)
26 references, click to expand
  1. Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes.
    Infect Immun. 1980 Jan;27(1):133-9 PMID: 6244225
  2. Herpes simplex virus glycoproteins: participation of individual herpes simplex virus type 1 glycoprotein antigens in immunocytolysis and their correlation with previously identified glycopolypeptides.
    J Virol. 1979 Dec;32(3):741-8 PMID: 229263
  3. Immunochemistry of herpes simplex virus glycoproteins.
    Curr Top Microbiol Immunol. 1980;90:67-106 PMID: 6159137
  4. Comparative structural analysis of glycoprotein gD of herpes simplex virus types 1 and 2.
    J Virol. 1980 Aug;35(2):428-35 PMID: 6255183
  5. gA and gB glycoproteins of herpes simplex virus type 1: two forms of a single polypeptide.
    J Virol. 1980 Dec;36(3):665-75 PMID: 6162034
  6. The preparation, efficacy and safety of 'antigenoid' vaccine NFU1 (S-L+) MRC toward prevention of herpes simplex virus infections in human subjects.
    Med Microbiol Immunol. 1980;169(1):39-51 PMID: 6258035
  7. Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice.
    Arch Virol. 1981;68(2):73-80 PMID: 6264897
  8. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease.
    Infect Immun. 1981 Oct;34(1):192-9 PMID: 6271681
  9. Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies.
    Infect Immun. 1982 Jan;35(1):363-7 PMID: 6172383
  10. Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody.
    J Virol. 1982 Mar;41(3):1099-1104 PMID: 6284965
  11. Pathogenesis of herpes simplex virus in congenitally athymic mice: the relative roles of cell-mediated and humoral immunity.
    J Gen Virol. 1982 Jun;60(Pt 2):225-33 PMID: 6286849
  12. Immune response to a DNA free herpes simplex vaccine in man.
    Arch Virol. 1982;73(1):61-7 PMID: 6289778
  13. Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2.
    Infect Immun. 1982 Sep;37(3):1132-7 PMID: 6290390
  14. Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection.
    Infect Immun. 1982 Oct;38(1):168-74 PMID: 6292092
  15. Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes.
    J Gen Virol. 1983 Feb;64 (Pt 2):443-7 PMID: 6601180
  16. Type-specific delayed hypersensitivity and protective immunity induced by isolated herpes simplex virus glycoprotein.
    J Immunol. 1983 Mar;130(3):1413-8 PMID: 6185584
  17. Isolation of a herpes simplex virus-specific antigenic fraction which stimulates the production of neutralizing antibody.
    J Virol. 1972 Nov;10(5):1021-30 PMID: 4344251
  18. Type-specific protein in herpes simplex virus envelope reacts with neutralising antibody.
    Nature. 1974 May 24;249(455):360-1 PMID: 4135313
  19. Immune mechanisms by which the spread of viral infections is stopped.
    Cell Immunol. 1974 Mar 30;11(1-3):478-83 PMID: 4376059
  20. Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunization.
    Science. 1975 May 30;188(4191):938-40 PMID: 166432
  21. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.
    J Immunol. 1976 Jan;116(1):35-40 PMID: 173758
  22. Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells.
    J Virol. 1976 Mar;17(3):991-1008 PMID: 176453
  23. Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine.
    Infect Immun. 1977 Jun;16(3):955-60 PMID: 197013
  24. Protective effect of an oral infection with herpes simplex virus type 1 against subsequent genital infection with herpes simplex virus type 2.
    Med Microbiol Immunol. 1978 Jul 4;165(2):119-27 PMID: 209295
  25. Type-common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope glycoprotein.
    J Virol. 1978 Jul;27(1):172-81 PMID: 80458
  26. Mechanism of recovery from systemic herpes simplex virus infection. I. Comparative effectiveness of antibody and reconstitution of immune spleen cells on immunosuppressed mice.
    J Infect Dis. 1980 Aug;142(2):163-74 PMID: 6967924
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1984-02-00
Pages
761-4
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC264368
Subset
IM
Grants
NIAID NIH HHS · AI-18289 · United States
NIDCR NIH HHS · DE-02623 · United States
NEI NIH HHS · EY-03894 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]